Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery business to Bain Capital for $287 million.

Hillenbrand has only owned Milacron since 2019, when it paid $1.9 billion for Milacron Holdings Corp. I did a double take, ...

Following the close of the transaction, Hillenbrand’s consolidated results will include a proportionate share of Milacron’s net income (or loss) as equity income at corporate. In fiscal year ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron business to Bain Capital, a leading private ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Milacron’s comprehensive suite of equipment offerings and services enables the production of everyday products used across the construction, automotive, packaging, consumer goods, and medical sectors.

Q1 2025 Management View CEO Kimberly Ryan highlighted the sale of a 51% stake in the Milacron injection molding and extrusion business to Bain Capital for $287 million, retaining a 49% stake. This ...

We believe this transaction not only delivers value for Hillenbrand and our shareholders, but also Milacron and its customers ...

Welcome to Hillenbrand's conference call where we will be discussing our fiscal first quarter performance as well as the sale of a majority stake in our Milacron injection molding and extrusion ...

Despite revenue declines, Hillenbrand Inc (HI) focuses on strategic divestitures and strong aftermarket performance to drive ...

Hillenbrand (NYSE: HI), Milacron’s current owner, will continue to remain a significant investor in the business. Since 1968, Milacron has been a global provider of highly engineered plastic ...

Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction ...